What does CUSIP 29604W108 represent in this 13F holders report?

CUSIP 29604W108 is the security identifier for PHXM - ERYTECH PHARMA - SPONSORED ADR used to aggregate holder disclosures.

How many institutions held PHXM - ERYTECH PHARMA - SPONSORED ADR in Q2 2022?

6 institutional investors reported PHXM - ERYTECH PHARMA - SPONSORED ADR for Q2 2022. Use the holders table for investor-level position and value details.

ERYTECH PHARMA - SPONSORED ADR (PHXM)

CUSIP: 29604W108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / SPONSORED ADR
Total 13F shares: 1,503,746
Share change: -1,848,046
Total reported value: $1,651,000
Price per share: $1.11
Number of holders: 6
Value change: -$3,333,017
Number of buys: 5
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 29604W108?
CUSIP 29604W108 identifies PHXM - ERYTECH PHARMA - SPONSORED ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 29604W108:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021

Institutional Holders of ERYTECH PHARMA - SPONSORED ADR (PHXM) as of Q2 2022

As of 30 Jun 2022, ERYTECH PHARMA - SPONSORED ADR (PHXM) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,503,746 shares. The largest 6 holders included BVF INC/IL, Vanguard Personalized Indexing Management, LLC, CITADEL ADVISORS LLC, GROUP ONE TRADING, L.P., UBS Group AG, and CREDIT SUISSE AG/. This page lists 6 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.